Current Gene Therapy

Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
pp. 111-133(23)
Authors: Amalfitano A.; Parks R.J.

Adenovirus As An Integrating Vector
pp. 135-144(10)
Authors: Mitani K.; Kubo S.

Second Generation Adeno-Associated Virus Type 2-based Gene Therapy Systems with the Potential for Preferential Integration into AAVS1
pp. 145-159(16)
Author: Owens R.A.

Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
pp. 161-171(11)
Authors: Loser P.; Huser A.; Hillgenberg M.; Kumin D.; Both G.W.; Hofimann C.

CFTR Gene Transfer to Lung Epithelium - On the Trail of a Target Cell
pp. 173-181(9)
Authors: O'Dea S.; Harrison D.J.

Intracellular Barriers to Non-Viral Gene Transfer
pp. 183-194(12)
Authors: Lechardeur D.; Lukacs G.L.

Bone Marrow Stromal Cells as Targets for Gene Therapy
pp. 195-209(15)
Authors: Damme A.Van; Driessche T.Vanden; Collen D.; Chuah M.K.L.

The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy
pp. 211-226(16)
Authors: Hombach A.; Heuser C.; Abken H.

Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
pp. 227-234(8)
Authors: Licht T.; Peschel C.

Genetic Vaccination for the Immunotherapy of B-Cell Malignancies
pp. 235-242(8)
Authors: Benvenuti F.; Burrone O.R.

Oncolytic Viruses: Programmable Tumour Hunters
pp. 243-254(12)
Authors: Bell J.C.; Garson K.A.; Lichty B.D.; Stojdl F.D.

Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
pp. 255-271(19)
Author: Brand K.